Quest Diagnostics Inc. is traded on the NYSE.
Explore more US and African stocks, read the latest market news, or compare African stock exchanges on Wallflake.
Quest Diagnostics Inc. is traded on the NYSE. Quest Diagnostics Inc. operates in the Healthcare sector and trades on the New York Stock Exchange under the ticker DGX.
Quest Diagnostics Inc. is listed on the New York Stock Exchange, where it trades under the ticker symbol DGX. It is classified in the Healthcare sector.
DGX last traded at USD 237.14 on 4 September 2026, unchanged on the session. Live prices for Quest Diagnostics Inc. update through the trading day on Wallflake.
Quest Diagnostics Inc. has a market capitalisation of approximately USD 26.17B, based on its closing price on 4 September 2026.
Over the past 52 weeks DGX has traded between a low of USD 171.18 and a high of USD 247.19.
Yes. Quest Diagnostics Inc. pays a dividend, with a trailing yield of 1.44%. Its payout ratio is approximately 26.11%.
DGX has a price-to-earnings (P/E) ratio of 25.20 and earnings per share (EPS) of USD 9.41. These figures are reported metrics, not a valuation opinion — Wallflake does not issue buy, sell or hold recommendations.
DGX shares are bought and sold through a broker licensed to trade on the New York Stock Exchange. You open an account with a licensed broker, fund it, and place an order quoting the ticker DGX. Wallflake is a market-data and research platform, not a broker, and does not execute trades or give investment advice. See our New York Stock Exchange guide for how the market works. Read the guide
Figures are drawn from Wallflake's market data and are provided for information only. Nothing here is investment advice or a recommendation to buy or sell any security.